相关实验视频

Updated: Jul 12, 2026

Assessing the Viability of a Synthetic Bacterial Consortium on the In Vitro Gut Host-microbe Interface
10:24

Assessing the Viability of a Synthetic Bacterial Consortium on the In Vitro Gut Host-microbe Interface

Published on: July 4, 2018

11.5K

对于冷化便微生物群产品的体外验证概念,重点是细菌活力

Sara A Sedeek1,2, Fedja Farowski1,3,4, Stella Youssafi3

  • 1Department of Internal Medicine II, Infectious Diseases, Goethe University Frankfurt, University Hospital Frankfurt, Frankfurt am Main, Germany.

World journal of microbiology & biotechnology
|February 26, 2025
PubMed
概括

解热化便微生物群 (LFM) 为复发性Clostridioides difficile感染 (rCDI) 提供了新鲜或冷便微生物群移植 (FMT) 的可行替代方案. 这种方法保持了细菌活力和代谢物水平,使存储更容易,治疗囊更少.

关键词:
克洛斯特里迪奥伊德斯困难菌细菌的活力 细菌的活力囊 囊 囊 囊便微生物群移植 便微生物群移植软化液化化是什么意思

更多相关视频

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota07:15

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota

Published on: July 31, 2019

9.5K
Analysis of Interactions between Endobiotics and Human Gut Microbiota Using In Vitro Bath Fermentation Systems00:06

Analysis of Interactions between Endobiotics and Human Gut Microbiota Using In Vitro Bath Fermentation Systems

Published on: August 23, 2019

6.8K

相关概念视频

In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...